Literature DB >> 31169101

An update on the epidemiology, length of stay, and cost of Kawasaki disease hospitalisation in the United States.

Laxmi V Ghimire1, Fu-Sheng Chou2, Narayan B Mahotra3, Sharan P Sharma4.   

Abstract

BACKGROUND: Kawasaki disease is an acute vasculitis of childhood and is the leading cause of acquired heart disease in the developed countries.
METHODS: Data from hospital discharge records were obtained from the National Kids Inpatient Database for years 2009 and 2012. Hospitalisations by months, hospital regions, timing of admission, insurance types, and ethnicity were analysed. Length of stay and total charges were also analysed.
RESULTS: There were 10,486 cases of Kawasaki disease from 12,678,005 children hospitalisation. Kawasaki disease was more common between 0 and 5 years old, in male, and in Asian. The January-March quarter had the highest rate compared to the lowest in the July-September quarter (OR=1.62, p < 0.001). Admissions on the weekend had longer length of stay [4.1 days (95 % CI: 3.97-4.31)] as compared to admissions on a weekday [3.72 days (95 % CI: 3.64-3.80), p < 0.001]. Blacks had the longest length of stay and whites had the shortest [4.33 days (95 % CI: 4.12-4.54 days) versus 3.60 days (95 % CI: 3.48-3.72 days), p < 0.001]. Coronary artery aneurysm was identified in 2.7 % of all patients with Kawasaki disease. Children with coronary artery aneurysm were hospitalised longer and had higher hospital charge. Age, admission during weekend, and the presence of coronary artery aneurysm had significant effect on the length of stay.
CONCLUSIONS: This report provides the most updated epidemiological information on Kawasaki disease hospitalisation. Age, admissions during weekend, and the presence of coronary artery aneurysm are significant contributors to the length of stay.

Entities:  

Keywords:  Kawasaki disease; United States; coronary aneurysm

Year:  2019        PMID: 31169101     DOI: 10.1017/S1047951119000982

Source DB:  PubMed          Journal:  Cardiol Young        ISSN: 1047-9511            Impact factor:   1.093


  4 in total

1.  Health care utilization and costs following Kawasaki disease.

Authors:  Cal Robinson; Rahul Chanchlani; Anastasia Gayowsky; Elizabeth Darling; Hsien Seow; Michelle Batthish
Journal:  Paediatr Child Health       Date:  2022-03-01       Impact factor: 2.600

2.  Neutrophil-Derived Semaphorin 4D Induces Inflammatory Cytokine Production of Endothelial Cells via Different Plexin Receptors in Kawasaki Disease.

Authors:  Junhua Huang; Shouzhen Wu; Sancheng Cao; Xieying Zhu; Shuwan Zhang
Journal:  Biomed Res Int       Date:  2020-12-16       Impact factor: 3.411

3.  A 10-year cross-sectional retrospective study on Kawasaki disease in Iranian children: incidence, clinical manifestations, complications, and treatment patterns.

Authors:  Payman Sadeghi; Anahita Izadi; Sayed Yousef Mojtahedi; Leila Khedmat; Mohsen Jafari; Azadeh Afshin; Pourya Yarahmadi; Effat Hosseinali Beigi
Journal:  BMC Infect Dis       Date:  2021-04-19       Impact factor: 3.090

4.  A Case of Incomplete and Atypical Kawasaki Disease Presenting with Retropharyngeal Involvement.

Authors:  Chiara Isidori; Lisa Sebastiani; Susanna Esposito
Journal:  Int J Environ Res Public Health       Date:  2019-09-05       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.